Zeynep Eroglu - Istanbul Ticaret University

基本信息

浏览量：81

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 180 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Quality of Life and Patient‐reported Toxicities in Patients with Advanced Merkel Cell Carcinoma Treated with Combined Nivolumab and Ipilimumab with or Without Stereotactic Body Radiation Therapy

Aasha I. Hoogland,Andrew S. Brohl,Brent J. Small, Lauren Michael,Evan Wuthrick,Zeynep Eroglu,Dukagjin Blakaj,Claire Verschraegen,Nikhil I. Khushalani,Heather S. L. Jim,Sungjune Kim

Cancer Medicine（2024）

引用0浏览0WOS引用

Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients with Advanced Cutaneous Cancers

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 9 (2024): 1011-1020

引用0浏览0WOS引用

Comparison of Vedolizumab and Ustekinumab Treatment Persistence in Anti-Tnf Experienced Crohn's Disease Patients

Z. Eroglu, V. Yilmaz,R. E. Er,I. Soykan,M. Toruner

JOURNAL OF CROHNS & COLITIS (2024): I1182-I1182

引用0浏览0引用

Comparison of Infliximab and Adalimumab Therapies Persistence in Patients with Ulcerative Colitis: Results from a Single Tertiary Turkish IBD Center Cohort

Z. Eroglu, V. Yilmaz, T. Guvenir,R. E. Er,M. Toruner

JOURNAL OF CROHNS & COLITIS (2024): I1318-I1318

引用0浏览0引用

Combined BRAF, MEK, and Heat-Shock Protein 90 (HSP90) Inhibition in Advanced BRAF V600-mutant Melanoma

Zeynep Eroglu,Y. Ann Chen,Inna Smalley,Jiannong Li,Joseph K. Markowitz,Andrew S. Brohl,Leticia Tetteh,Hayley Taylor,Vernon K. Sondak,Nikhil I. Khushalani,Keiran S. M. Smalley

CANCERno. 2 (2024): 232-243

引用2浏览0WOS引用

Abstract 3734: Tumoral and systemic immune modulation with neoadjuvant (NeoAd) intratumoral (IT) TAVO-EP (plasmid IL-12 electro gene transfer) and nivolumab (NIVO) in patients (pts) with operable locoregionally advanced melanoma

Ahmad A. Tarhini,Zeynep Eroglu,Jonathan S. Zager,Ricardo J. Gonzalez,Amod A. Sarnaik,C Wayne Cruse,Deanryan B. De Aquino,Edith Abraham, Diana M. Acevedo,Allison Richards,Michael J. Schell,Denise Kalos,Pei-Ling Chen,Jane L. Messina,David A. Canton,Vernon K. Sondak

Cancer Researchno. 6_Supplement (2024): 3734-3734

引用0浏览0引用

Patient Reported Outcomes and Patient Experiences of Immune Checkpoint Modulators for Advanced or Recurrent Melanoma: a Mixed Methods Study

Danielle B. Tometich,Carley Geiss,Melinda L. Maconi,Melody Chavez,Aasha I. Hoogland,Xiaoyin Li, Amarilis Nieves-Lopez,Yvelise Rodriguez,Crystal Bryant,Andrew S. Brohl,Zeynep Eroglu,Joseph Markowitz,Ahmad A. Tarhini,Patrick Hwu,Nikhil I. Khushalani,Heather S. L. Jim

Supportive Care in Cancerno. 6 (2024): 1-9

引用0浏览0WOS引用

1103P Real-world Efficacy of Relatlimab and Nivolumab in Advanced or Resectable Melanoma

L. Karapetyan, S. Aflatooni, K. Ward, B. Withycombe,D. Kalos,Q. Mo,Z. Eroglu,A.S. Brohl, J. Markowitz,A. Tarhini, J. Messina, K.Y. Tsai, M. Perez,J.S. Zager,A. Sarnaik,R.I. Neves, V. Sondak,N.I. Khushalani

Annals of Oncology (2024)

引用0浏览0引用

Durability of Response to Immune Checkpoint Blockade Following Treatment Discontinuation and Efficacy of Rechallenge in Advanced Merkel Cell Carcinoma

Tanya Ramadoss, Matthew Nichols, Christian Palacios,Zeynep Eroglu,Joseph Markowitz,Lilit Karapetyan,Ahmad A. Tarhini,Evan J. Wuthrick, Vernon K. Sondak,Nikhil Khushalani,Kenneth Y. Tsai,Andrew S. Brohl

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 9 (2024)

引用0浏览0WOS引用

Abstract CT057: Phase 1/2 trial of trametinib + ceritinib in patients with unresectable melanoma

Zeynep Eroglu, Vivien Yin,Joseph Markowitz,Andrew Brohl,Ahmad A. Tarhini,Wenyi Fan,Deanryan De Aquino,Ann Chen,Uwe Rix,Nikhil I. Khushalani,Keiran Smalley

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn